Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Cancer » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
_Cancer Research Journal - This journal ceased publication after 4#4 (2010). Back Issues are available.
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
01.Experimental Leukemia: History, Biology and Genetics
02.Cancer Metastasis Research: Pathological Insight
03.Eye Cancer Research Progress
04.Mesothelioma from Bench Side to Clinic
05.Photodynamic Therapy: New Research
06.Cancer and Stem Cells
07.Oncology Social Work Practice in the Care of Breast and Ovarian Cancer Survivors
08.Progress in Oral Cancer Research
09.New Research on Cutaneous Lymphomas
10.Aromatase Inhibitors: Types, Mode of Action and Indications
Notifications more
NotificationsNotify me of updates to Trends in Ovarian Cancer Research (Horizons in Cancer Research, Volume 2)
Tell A Friend
Tell someone you know about this product.
Trends in Ovarian Cancer Research (Horizons in Cancer Research, Volume 2)
Retail Price: $160.00
10% Online Discount
You Pay:

Editors: Bardos, A. P.
Book Description:
Ovarian cancer is cancer that begins in the cells that constitute the ovaries, including surface epithelial cells, germ cells, and the sex cord-stromal cells. Cancer cells that metastasize from other organ sites to the ovary (most commonly breast or colon cancers) are not then considered ovarian cancer. According to the American Cancer Society, ovarian cancer accounts for 4 percent of all cancers among women and ranks fifth as a cause of their deaths from cancer. The American Cancer Society statistics for ovarian cancer estimate that there will be 25,400 new cases and 14,300 deaths in 2003. The death rate for this disease has not changed much in the last 50 years. Unfortunately, almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage—i.e., has spread to the upper abdomen (stage III) or beyond (stage IV). The 5-year survival rate for these women is only 15 to 20 percent, whereas the 5-year survival rate for stage I disease patients approaches 90 percent and for stage II disease patients approaches 70 percent. Ovarian tumors are named according to the type of cells the tumor started from and whether the tumor is benign or cancerous. The three main types of ovarian tumors are: Epithelial Tumors, Germ Cell Tumors and Stromal Tumors. This new book brings together new and leading-edge research from around the world.

Please click on a chapter below to purchase separately

Chapter 1 - The Value Of Imaging In Ovarian Cancer (pp. 1-25)
Authors / Editors: Balestreri, L. , Morra, A. , Borsatti, E. and Morassut, S. (Centro di Riferimento Oncologico, Italy)

Chapter 2 - Tyrphostins And Retinoids Control Growth, Erbb And Rar Expression In Ovarian Cancer Cells (pp. 27-42)
Authors / Editors: Grunt, Thomas W. (University Hospital, Vienna, Austria)

Chapter 3 - Possible Role Of Hypoixa In Peritoneal Dissemination Of Ovarian Cancer Cells: A Review (pp. 43-53)
Authors / Editors: Horiuchi, Akiko and Konishi, Ikuo (Shinshu University School of Medicine, Japan)

Chapter 4 - The Value Of Ca125 In The Management Of Epithelial Ovarian Cancer (pp. 55-74)
Authors / Editors: Tsuda, Hiroshi and Bandera, Christina A. (Osaka City General Hospital, Osaka, Japan and Harvard Medical School)

Chapter 5 - Circulating Markers (Ca125, Tps, Vegf, Sil-2ralpha) As Indicators Of Different Biological Behavior Of Ovarian Carcinomas (pp. 75-92)
Authors / Editors: Harlozinska, A. , Sedlaczek, P. , Frydecka, I. and Grybos, M. (Wroclaw Medical University, Poland)

Chapter 6 - Tp53 Status Determines Prognostic And Predictive Factors In Ovarian Carcinomas (pp. 93-111)
Authors / Editors: Kupryjańczyk, Jolanta (The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Poland)

Chapter 7 - Tumor Grade May Distinguish Recurrence In Ovarian Cancer (pp. 113-129)
Authors / Editors: Zhao, Yan (Beijing University Medical School, China); Barber, Hugh R. K. (Weill Medical College of Cornell University); Declercq, Katrien (SAS Institute, Brussels, Belgium); Tornieporth, Nadia (GlaxoSmithKline Biologicals, Belgium); Arzimanoglou, Iordanis I. (Weill Medical College of Cornell University)

Chapter 8 - A Peculiar Presentation Of Ovarian Carcinoma: Paraneoplastic Cerebellar Degeneration (pp. 131-138)
Authors / Editors: Bartoš, A. (University Hospital Královské Vinohrady, Czech Republic)

Chapter 9 - Ovarian Mucinous Cystadenomas In Childhood (pp. 139-161)
Authors / Editors: Yazici, Mesut (Adnan Menderes University, Turkey)

      Horizons in Cancer Research
   Binding: Hardcover
   Pub. Date: 2004
   ISBN: 1-59454-023-3
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Customers who bought this product also purchased
Trends in Electrochemistry Research
Trends in Electrochemistry Research
New Developments in Electrochemistry Research
New Developments in Electrochemistry Research

Circulating Markers (Ca125, Tps, Vegf, Sil-2ralpha) As Indicators Of Different Biological Behavior Of Ovarian Carcinomas (pp. 75-92)
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2022

Trends in Ovarian Cancer Research (Horizons in Cancer Research, Volume 2)